Study of the Bruton's Tyrosine Kinase Inhibitor in Subjects With Relapsed or Relapsed and Refractory Multiple Myeloma
Clinical trial NCT01478581 · COMPLETED
Trial details
- NCT number
- NCT01478581
- Sponsor
- Pharmacyclics LLC.
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2012-03-01
- Primary completion
- 2018-08-01
- Enrollment
- 92
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.